Measuring the response of the pupil to light stimulating the eye is a non-invasive and easy way to assess multiple sclerosis (MS) severity and progression, researchers report.
These findings were presented at the 4th Congress of the European Academy of Neurology (EAN) that recently took place in Lisbon. The presentation was titled “Reduced pupillary modulation in patients with relapsing-remitting Multiple Sclerosis is associated with longer disease duration and higher disease severity” (abstract on page 80).
The pupil, the black spot at the center of the colored structure (iris) of the eye, controls the amount of light that enters the eye by contracting (closing) or expanding (dilating). When the eye encounters a strong light, the pupil rapidly contracts — and when little light is available, the pupil widens or expands to allow as much light as possible to enter.
Abnormal pupil reactions to light are common among RRMS patients, and believed to be due to MS lesions in the nervous system. Still, the extent to which this visual manifestation of MS correlates with disease duration and severity is not fully understood.
Researchers at the University of Erlangen-Nuremberg, in Germany, examined 85 RRMS patients (mean age 37.4), and evaluated their pupil’s diameter, dilation and constriction velocity, and reflex response.
They found that the pupil’s diameter and “early re-dilatation velocity” — speed at which the pupil reacted immediate to strong light — negatively correlated with a patient’s age, disease duration, and disability scores. This means that the worse result in these tests were seen in older RRMS patients, those with longer disease duration, and those with worse disability.
Repeatedly quick pupil response — or early re-dilation velocity — was positively associated with the functional status of the patients, meaning that better results here reflected lesser disability, in terms of both movement (walking and ambulation, hand and arm function, etc.) and cognition.
Slower and poorer pupil response to light was linked to longer disease duration and older age, as well as worse disability and functional scores.
Based on these results, the team concluded that “the decrease in sympathetic and parasympathetic pupillary autonomic modulation was associated with longer disease-duration and higher disease-severity.”
Because pupil features and reactivity can be easily and non-invasively examined using light reflex pupillography, results seen with such tests should make them an attractive clinical marker of “MS severity and progression,” the researchers suggested.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?